METHOD AND APPARATUS FOR DETECTING NON-SUSTAINING VENTRICULAR TACHYARRHYTHMIA

• US 20100152803A1
• Filed: 02/19/2010
• Published: 06/17/2010
• Est. Priority Date: 06/16/2006
• Status: Active Grant

• Current Assignee: Jaeho Kim, Yunlong Zhang
• Original Assignee: Jaeho Kim, Yunlong Zhang
• Inventors: Kim, Jaeho, Zhang, Yunlong
• Granted Patent: US 8,265,751 B2
• Time in Patent Office: Days
• US Class Current: 607/14
• CPC Class Codes: A61N 1/3621 for treating or preventing abnormally high heart rate
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

An implantable medical device controls an anti-tachyarrhythmia therapy by detecting a tachyarrhythmia episode from a cardiac signal and analyzing the detected tachyarrhythmia episode in a tachyarrhythmia detection and analysis process to determine whether the anti-tachyarrhythmia therapy needs to be delivered. The tachyarrhythmia detection and classification process includes detection of inhibitory events each indicating that the tachyarrhythmia episode is of a type not to be treated by the anti-tachyarrhythmia therapy or that the tachyarrhythmia episode is not sustaining. The detection of each of the inhibitory events causes the tachyarrhythmia detection and classification process to be restarted or extended, or the delivery of the anti-tachyarrhythmia therapy to be withheld.

Claims

1. An implantable medical device, comprising:

a sensing circuit configured to sense a cardiac signal; and

a controller configured to control delivery of an anti-tachyarrhythmia therapy, the controller including;

a tachyarrhythmia detector coupled to the sensing circuit, the tachyarrhythmia detector configured to detect an initiation event indicative of a tachyarrhythmia episode from the cardiac signal, start a tachyarrhythmia detection and classification process in response to a detection of the initiation event, and to restart or extend the tachyarrhythmia detection and classification process in response to a detection of an inhibitory event indicative of a need to inhibit the delivery of the anti-tachyarrhythmia therapy, the tachyarrhythmia detection and classification process determining whether the tachyarrhythmia episode sustains and is to be treated by the anti-tachyarrhythmia therapy;

a beat detector coupled to the sensing circuit, the beat detector configured to detect heart beats from the cardiac signal;

a heart rate detector coupled to the beat detector, the heart rate detector configured to detect a heart rate associated with each of the detected heart beats;

a beat classifier coupled to the heart rate detector, the beat classifier configured to classify each beat of the detected heart beat as a fast beat in response to the each beat associated with a heart rate within a tachyarrhythmia detection zone and a show beat in response to the each beat associated with a heart rate below the tachyarrhythmia detection zone or being a paced heart beat; and

an inhibitory event detector coupled to the tachyarrhythmia detector and the beat classifier, the inhibitory event detector including an arrhythmia pattern detector configured to detect a specified pattern including repetitive sequences of the fast and slow beats and indicate a detection of the inhibitory event in response to a detection of the specified pattern.

2. The implantable medical device of claim 1, wherein the arrhythmia pattern detector is configured to indicate the detection of the inhibitory event in response to a detection of a pattern of a specified number (F) of the fast beats followed by a specified number (S) of the slow beats.

3. The implantable medical device of claim 2, wherein the arrhythmia pattern detector is configured to indicate the detection of the inhibitory event in response to detection of a pattern of F being equal to or greater than 3 and S being equal to 1.

4. The implantable medical device of claim 2, wherein the arrhythmia pattern detector is configured to indicate the detection of the inhibitory event in response to detection of a pattern of F being equal to or greater than 4 and S being equal to 2.

5. The implantable medical device of claim 2, wherein the arrhythmia pattern detector is configured to indicate the detection of the inhibitory event in response to detection of a pattern of F being equal to or greater than 8 and S being equal to 3 or 4.

6. The implantable medical device of claim 2, wherein the arrhythmia pattern detector is configured to indicate the detection of the inhibitory event in response to detection of at least two beat sequences having different ratios of F to S each falling into one of a plurality of specified patterns.

7. The implantable medical device of claim 1, wherein the tachyarrhythmia detector comprises a tachyarrhythmia detection module including:

a detection timer configured to start a tachyarrhythmia detection window in response to the detection of the initiation event, the tachyarrhythmia detection window including a specified number of consecutively detected heart beats; and

a detection declaration module configured to declare a detection of tachyarrhythmia in response to a number of the fast beats detected during the tachyarrhythmia detection window being equal to or exceeding a specified detection threshold.

8. The implantable medical device of claim 7, wherein the detection timer is configured to restart the tachyarrhythmia detection window in response to the detection of the inhibitory event.

9. The implantable medical device of claim 8, wherein the tachyarrhythmia detector comprises a tachyarrhythmia verification module including:

a duration timer configured to start a tachyarrhythmia verification duration in response to a declaration of the detection of tachyarrhythmia and extend the tachyarrhythmia verification duration in response to the detection of the inhibitory event during the tachyarrhythmia verification duration; and

a verification declaration module configured to declare that the tachyarrhythmia episode sustains in response to a number of the fast beats detected during a verification window being equal to or exceeding a predetermined verification threshold, the verification window being a moving window ending with each heart beat detected during the tachyarrhythmia verification duration and including a specified number of consecutively detected heart beats.

10. The implantable medical device of claim 9, wherein the tachyarrhythmia detector further comprises:

a reconfirmation timer configured to start a tachyarrhythmia reconfirmation window in response to completion of a preparation for the delivery of the anti-tachyarrhythmia therapy and restart the tachyarrhythmia reconfirmation window in response to the predetermined type inhibitory event being detected during the tachyarrhythmia reconfirmation window, the tachyarrhythmia reconfirmation window including a predetermined number of consecutively detected beats; and

a reconfirmation declaration module configured to declare a reconfirmation of tachyarrhythmia in response to a number of the fast beats detected during the tachyarrhythmia reconfirmation window being equal to or exceeding a predetermined reconfirmation threshold and the predetermined type inhibitory event not being detected during the tachyarrhythmia reconfirmation window.

11. A method for operating an implantable medical device, the method comprising:

sensing a cardiac signal;

detecting heart beats from the cardiac signal;

detecting a heart rate associated with each of the detected heart beats;

classifying each beat of the detected heart beats a fast beat in response to the each beat associated with a heart rate within a tachyarrhythmia detection zone and a slow beat in response to the each beat associated with a heart rate below the tachyarrhythmia detection zone or being a paced heart beat;

detecting an initiation event indicative of a tachyarrhythmia episode from the cardiac signal;

starting a tachyarrhythmia detection and classification process in response to a detection of the initiation event;

detecting a specified pattern including repetitive sequences of the fast and slow beats;

indicating a detection of an inhibitory event indicative of a need to inhibit a delivery of an anti-tachyarrhythmia therapy is response to a detection of the specified pattern; and

restarting or extending the tachyarrhythmia detection and classification process in response to detection of the inhibitory event.

12. The method of claim 11, wherein indicating the detection of the inhibitory event comprises indicating the detection of the inhibitory event in response to detection of a pattern of a specified number (F) of the fast beats followed by a specified number (S) of the slow beats.

13. The method of claim 12, wherein indicating the detection of the inhibitory event comprises indicating the detection of the inhibitory event in response to detection of a pattern of F being equal to or greater than 3 and S being equal to 1.

14. The method of claim 12, wherein indicating the detection of the inhibitory event comprises indicating the detection of the inhibitory event in response to detection of a pattern of F being equal to or greater than 4 and S being equal to 2.

15. The method of claim 12, wherein indicating the detection of the inhibitory event comprises indicating the detection of the inhibitory event t in response to detection of a pattern of F being equal to or greater than 8 and S being equal to 3 or 4.

16. The method of claim 12, wherein indicating the detection of the inhibitory event comprises indicating the detection of the inhibitory event in response to detection of at least two beat sequences having different ratios of F to S each falling into one of a plurality of specified patterns.

17. The method of claim 11, wherein starting the tachyarrhythmia detection and classification process comprises:

starting a tachyarrhythmia detection window in response to the detection of the initiation event, the tachyarrhythmia detection window including a specified number of consecutively detected heart beats; and

declaring a detection of tachyarrhythmia in response to a number of the fast beats detected during the tachyarrhythmia detection window being equal to or exceeding a specified detection threshold.

18. The method of claim 17, comprising restarting the tachyarrhythmia detection window in response to the detection of the inhibitory event.

19. The method of claim 17, comprising:

starting a tachyarrhythmia verification duration in response to a declaration of the detection of tachyarrhythmia;

extending the tachyarrhythmia verification duration in response to the detection of the inhibitory event during the tachyarrhythmia verification duration; and

declaring that the tachyarrhythmia episode sustains in response to a number of the fast beats detected during a verification window being equal to or exceeding a predetermined verification threshold, the verification window being a moving window ending with each heart beat detected during the tachyarrhythmia verification duration and including a specified number of consecutively detected heart beats.

20. The method of claim 19, comprising:

starting a tachyarrhythmia reconfirmation window in response to completion of a preparation for the delivery of the anti-tachyarrhythmia therapy, the tachyarrhythmia reconfirmation window including a specified number of consecutively detected beats;

restarting the tachyarrhythmia reconfirmation window in response to the predetermined type inhibitory event being detected during the tachyarrhythmia reconfirmation window; and

declaring a reconfirmation of tachyarrhythmia in response to a number of the fast beats detected during the tachyarrhythmia reconfirmation window being equal to or exceeding a predetermined reconfirmation threshold and the predetermined type inhibitory event not being detected during the tachyarrhythmia reconfirmation window.